ENDRA Life Sciences (NDRA) Operating Income (2016 - 2021)
Historic Operating Income for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' Operating Income fell 3625.0% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.5 million, marking a year-over-year increase of 3.14%. This contributed to the annual value of -$10.8 million for FY2024, which is 281.74% down from last year.
- According to the latest figures from Q4 2021, ENDRA Life Sciences' Operating Income is -$3.1 million, which was down 3625.0% from -$2.7 million recorded in Q3 2021.
- ENDRA Life Sciences' Operating Income's 5-year high stood at -$360697.0 during Q1 2017, with a 5-year trough of -$3.3 million in Q3 2020.
- Moreover, its 5-year median value for Operating Income was -$2.6 million (2019), whereas its average is -$2.4 million.
- In the last 5 years, ENDRA Life Sciences' Operating Income plummeted by 68670.41% in 2018 and then skyrocketed by 2799.16% in 2020.
- Over the past 5 years, ENDRA Life Sciences' Operating Income (Quarter) stood at -$2.3 million in 2017, then increased by 12.79% to -$2.0 million in 2018, then crashed by 56.31% to -$3.1 million in 2019, then increased by 27.99% to -$2.3 million in 2020, then plummeted by 36.25% to -$3.1 million in 2021.
- Its Operating Income was -$3.1 million in Q4 2021, compared to -$2.7 million in Q3 2021 and -$3.2 million in Q2 2021.